West Pharmaceutical Services (MEX:WST) Cyclically Adjusted FCF per Share: MXN88.79 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:WST West Pharmaceutical Services Inc MEX:WST
94 GF Score
Price MXN5,112.51
GF Value MXN5,282.62
! 9 Warning Signs
View Full Analysis

What is West Pharmaceutical Services Cyclically Adjusted FCF per Share?

West Pharmaceutical Services MEX:WST 94 Cyclically Adjusted FCF per Share is MXN88.79 as of Jun. 2026. GuruFocus rates MEX:WST with a GF Score™ of 94/100 and a GF Value™ of MXN5,282.62. The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

West Pharmaceutical Services's adjusted free cash flow per share for the three months ended in Jun. 2026 was MXN19.604. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN88.79 for the trailing ten years ended in Jun. 2026.

During the past 12 months, West Pharmaceutical Services's average Cyclically Adjusted FCF Growth Rate was 15.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 20.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 23.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of West Pharmaceutical Services was 33.90% per year. The lowest was -10.40% per year. And the median was 15.00% per year.

As of today (2026-09-16), West Pharmaceutical Services's current stock price is MXN5112.51. West Pharmaceutical Services's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was MXN88.79. West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF of today is 57.58.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of West Pharmaceutical Services was 243.13. The lowest was 51.90. And the median was 112.90.


West Pharmaceutical Services  (MEX:WST) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=5112.51/88.793
=57.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of West Pharmaceutical Services was 243.13. The lowest was 51.90. And the median was 112.90.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


West Pharmaceutical Services Cyclically Adjusted FCF per Share Related Terms


West Pharmaceutical Services Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for West Pharmaceutical Services's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

West Pharmaceutical Services Cyclically Adjusted FCF per Share Chart

West Pharmaceutical Services Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.18 54.17 64.14 71.12 83.03

West Pharmaceutical Services Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.39 79.95 83.28 87.22 88.79

MEX:WST vs MDLN, SOLV, COO: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Pharmaceutical Services Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF falls into.


MEX:WST
94GF Score
West Pharmaceutical Services Inc MEX:WST
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

West Pharmaceutical Services Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, West Pharmaceutical Services's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=19.604/333.9520*333.9520
=19.604

Current CPI (Jun. 2026) = 333.9520.

West Pharmaceutical Services Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 4.974 241.428 6.880
201612 6.798 241.432 9.403
201703 -4.554 243.801 -6.238
201706 14.044 244.955 19.146
201709 9.382 246.819 12.694
201712 14.179 246.524 19.207
201803 4.218 249.554 5.645
201806 16.142 251.989 21.392
201809 15.080 252.439 19.949
201812 12.913 251.233 17.165
201903 4.794 254.202 6.298
201906 19.541 256.143 25.477
201909 20.048 256.759 26.075
201912 17.093 256.974 22.213
202003 6.638 258.115 8.588
202006 35.383 257.797 45.835
202009 18.539 260.280 23.786
202012 20.367 260.474 26.112
202103 9.131 264.877 11.512
202106 22.994 271.696 28.263
202109 32.904 274.310 40.058
202112 25.249 278.802 30.244
202203 23.042 287.504 26.765
202206 27.794 296.311 31.325
202209 30.199 296.808 33.978
202212 33.163 296.797 37.315
202303 13.802 301.836 15.271
202306 21.307 305.109 23.321
202309 29.176 307.789 31.656
202312 32.425 306.746 35.301
202403 6.312 312.332 6.749
202406 15.254 314.175 16.214
202409 27.604 315.301 29.237
202412 26.399 315.605 27.934
202503 16.244 319.799 16.963
202506 26.736 322.561 27.680
202509 32.395 324.800 33.308
202512 42.724 324.054 44.029
202603 11.448 330.213 11.578
202606 19.604 333.952 19.604

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN88.79 mean?
West Pharmaceutical Services (MEX:WST) has a Cyclically Adjusted FCF per Share of MXN88.79 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on West Pharmaceutical Services and its competitors.
Is West Pharmaceutical Services' Cyclically Adjusted FCF per Share too high?
West Pharmaceutical Services' current Cyclically Adjusted FCF per Share is MXN88.79. Overall, West Pharmaceutical Services has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does West Pharmaceutical Services' Cyclically Adjusted FCF per Share compare to MDLN and SOLV?
West Pharmaceutical Services' Cyclically Adjusted FCF per Share of MXN88.79 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on West Pharmaceutical Services and its competitors. West Pharmaceutical Services's current Cyclically Adjusted FCF per Share is MXN88.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Pharmaceutical Services stock overvalued right now?
West Pharmaceutical Services (MEX:WST) has a current Cyclically Adjusted FCF per Share of MXN88.79. The stock's GF Value™ is MXN5,282.62, compared to a current price of MXN5,112.51 — trading 3.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN88.79. West Pharmaceutical Services' overall GF Score™ is 94/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For West Pharmaceutical Services (MEX:WST), the current Cyclically Adjusted FCF per Share is MXN88.79 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is West Pharmaceutical Services (MEX:WST) Overvalued in 2026?

Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued. The current stock price of MXN5,112.51 is trading 3.2% below its estimated GF Value™ of MXN5,282.62.

Key valuation signals for MEX:WST:

  • Cyclically Adjusted FCF per Share: MXN88.79
  • GF Value™: MXN5,282.62 vs. price of MXN5,112.51 (3.2% below fair value)
  • GF Score™: 94/100 with 9 warning signs

No single metric tells the full story. See the MEX:WST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


West Pharmaceutical Services Business Description

Address 530 Herman O. West Drive, Exton, PA, USA, 19341-1147
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
94GF Score

Get the complete analysis for MEX:WST

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN5,112.51
Price
MXN5,282.62
GF Value